Australia's Immuron eyes best day in 3 months on HY total sales
** Shares of Australian biopharmaceutical co Immuron
IMC.AX rise as much as 10.5% to A$0.084, set for their best
day since Oct 11, if gains hold
** Stock hits highest level since Dec 15
** Co posts half-yearly total sales of A$2.4 million ($1.60
million)
** 254,611 shares change hands at 2340 GMT, 1.9 times the
30-day average volume
** Stock fell ~10% in 2023
($1 = 1.5033 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Recent news on Immuron
See all newsBrief: Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
Australia's Immuron hits near 1.5-month high on distribution deal in US
Brief: Immuron Executes Exclusive Distribution Agreement For Proibs In The United States
Brief: Immuron Reports FY26 Preliminary Results
Brief: Immuron Posts FY Revenue From Ordinary Activities Of A$7.71 Million